Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro.

Schmidt AJ, Krieg JC, Clement HW, Hemmeter UM, Schulz E, Vedder H, Heiser P.

J Psychopharmacol. 2010 Mar;24(3):349-54. doi: 10.1177/0269881108096506. Epub 2008 Aug 28.

PMID:
18755815
2.

Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells.

Schmidt AJ, Krieg JC, Clement HW, Gebhardt S, Schulz E, Heiser P.

J Psychopharmacol. 2010 Dec;24(12):1829-33. doi: 10.1177/0269881109105563. Epub 2009 Jul 15.

PMID:
19605603
3.

The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.

Melkersson K, Jansson E.

Neuro Endocrinol Lett. 2005 Jun;26(3):205-8.

PMID:
15990722
4.

Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells.

Bai O, Xu H, Li XM.

Life Sci. 2006 Jul 4;79(6):570-4. Epub 2006 Mar 2.

PMID:
16513140
5.

Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.

Dremencov E, El Mansari M, Blier P.

Psychopharmacology (Berl). 2007 Sep;194(1):63-72. Epub 2007 May 27.

PMID:
17530476
6.

Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.

Celikyurt IK, Kayir H, Ulak G, Erden FB, Ulusoy GK, Uzbay TI.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):528-36. doi: 10.1016/j.pnpbp.2010.12.009. Epub 2010 Dec 17.

PMID:
21168466
7.

Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro.

Heiser P, Enning F, Krieg JC, Vedder H.

J Psychopharmacol. 2007 Nov;21(8):851-6. Epub 2007 Sep 19.

PMID:
17881431
8.
10.

Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.

Storch A, Burkhardt K, Ludolph AC, Schwarz J.

J Neurochem. 2000 Dec;75(6):2259-69.

11.

Pharmacokinetic-pharmacodynamic modeling of risperidone effects on electroencephalography in healthy volunteers.

Lee DY, Lee KU, Kwon JS, Jang IJ, Cho MJ, Shin SG, Woo JI.

Psychopharmacology (Berl). 1999 Jun;144(3):272-8.

PMID:
10435394
12.

Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.

Wang JS, Zhu HJ, Markowitz JS, Donovan JL, DeVane CL.

Psychopharmacology (Berl). 2006 Sep;187(4):415-23. Epub 2006 Jun 30.

PMID:
16810505
13.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

14.

Impact of plant extracts tested in attention-deficit/hyperactivity disorder treatment on cell survival and energy metabolism in human neuroblastoma SH-SY5Y cells.

Schmidt AJ, Krieg JC, Hemmeter UM, Kircher T, Schulz E, Clement HW, Heiser P.

Phytother Res. 2010 Oct;24(10):1549-53. doi: 10.1002/ptr.3198.

PMID:
20878709
15.

Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.

Smith JA, Goudie AJ.

Exp Clin Psychopharmacol. 2002 Nov;10(4):376-84.

PMID:
12498334
16.

Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.

Jung SM, Kim KA, Cho HK, Jung IG, Park PW, Byun WT, Park JY.

Clin Pharmacol Ther. 2005 Nov;78(5):520-8. Epub 2005 Sep 26.

PMID:
16321618
17.

Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.

Fisher DS, Partridge SJ, Handley SA, Flanagan RJ.

Forensic Sci Int. 2013 Jun 10;229(1-3):151-6. doi: 10.1016/j.forsciint.2013.03.021. Epub 2013 Apr 6.

PMID:
23570966
18.

Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism.

Dwyer DS, Lu XH, Bradley RJ.

Brain Res. 2003 May 2;971(1):31-9.

PMID:
12691834

Supplemental Content

Support Center